Sale!

GALNT3 Gene Tumoral calcinosis hyperphosphatemic familial type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GALNT3 Gene Test for Tumoral Calcinosis Hyperphosphatemic Familial Type 1 is a specialized genetic test available at DNA Labs UAE, designed to diagnose this rare genetic disorder. Tumoral calcinosis hyperphosphatemic familial type 1 is characterized by the abnormal deposition of calcium phosphate in the skin and other tissues, leading to painful lumps. This condition is caused by mutations in the GALNT3 gene, which plays a crucial role in regulating phosphate levels in the body.

The test involves analyzing the patient’s DNA to identify mutations in the GALNT3 gene, providing crucial information for diagnosis, treatment planning, and genetic counseling. By pinpointing the exact genetic cause of the condition, healthcare providers can offer more targeted and effective interventions.

At DNA Labs UAE, the cost of the GALNT3 Gene Test for Tumoral Calcinosis Hyperphosphatemic Familial Type 1 is set at 4400 AED. This cost reflects the comprehensive nature of the test, encompassing the sophisticated techniques and expertise required to accurately identify mutations in the GALNT3 gene. Patients and families opting for this test can expect reliable results, contributing to a better understanding of the condition and guiding the path forward for management and care.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GALNT3 Gene Tumoral calcinosis hyperphosphatemic familial type 1 Genetic Test

Are you or your family members experiencing symptoms of tumoral calcinosis, hyperphosphatemic, familial, type 1? DNA Labs UAE offers the GALNT3 Gene Tumoral calcinosis hyperphosphatemic familial type 1 Genetic Test to help diagnose and manage this rare genetic disorder.

Test Details

The GALNT3 gene is associated with tumoral calcinosis, hyperphosphatemic, familial, type 1 (TCHP1), a rare genetic disorder characterized by the abnormal deposition of calcium phosphate crystals in soft tissues. This leads to the formation of tumor-like masses, which can cause pain, limited joint mobility, and other complications.

Our NGS (Next-Generation Sequencing) genetic testing method allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of an individual’s genetic makeup. In the case of TCHP1, this test can identify mutations or variations in the GALNT3 gene, helping to confirm a diagnosis.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the GALNT3 Gene Tumoral calcinosis hyperphosphatemic familial type 1 Genetic Test, it is important to provide a clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by TCHP1. This information aids in the accurate interpretation of the test results and allows for appropriate management of the disorder.

Benefits of Genetic Testing for TCHP1

Genetic testing for TCHP1 can be highly beneficial for individuals with symptoms suggestive of the condition, as well as their family members who may be at risk. Some of the advantages of this test include:

  • Early detection of the disorder
  • Accurate diagnosis confirmation
  • Appropriate management strategies
  • Valuable information for genetic counseling and family planning purposes

It is crucial to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors. These professionals can provide the necessary guidance and support throughout the testing process.

Test Name GALNT3 Gene Tumoral calcinosis hyperphosphatemic familial type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GALNT3 Gene Tumoral calcinosis, hyperphosphatemic, familial, type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Tumoral calcinosis, hyperphosphatemic, familial, type 1
Test Details

The GALNT3 gene is associated with a rare genetic disorder called tumoral calcinosis, hyperphosphatemic, familial, type 1 (TCHP1). TCHP1 is characterized by the abnormal deposition of calcium phosphate crystals in various soft tissues, leading to the formation of tumor-like masses. These masses can cause pain, limited joint mobility, and other complications.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. In the context of TCHP1, NGS genetic testing can identify mutations or variations in the GALNT3 gene, helping to confirm a diagnosis.

Genetic testing for TCHP1 can be beneficial for individuals with symptoms suggestive of the condition, as well as for their family members who may be at risk. It allows for early detection, accurate diagnosis, and appropriate management of the disorder. Additionally, genetic testing can provide valuable information for genetic counseling and family planning purposes.

It’s important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support throughout the testing process.